Dorman, Klara
Gerckens, Miriam
Kruger, Stephan
Krueger, Kimberly
Mayer, Zsuzsanna
Rupp, Alexander
Zhang, Danmei
Weiss, Lena
Westphalen, C. Benedikt
Haas, Michael
Guenther, Michael
Ormanns, Steffen
Klawonn, Frank
Werner, Jens
von Bergwelt-Baildon, Michael
Heinemann, Volker
Boeck, Stefan http://orcid.org/0000-0002-1922-2127
Holdenrieder, Stefan
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 8 May 2022
Accepted: 3 June 2022
First Online: 23 June 2022
Declarations
:
: KD has received travel/accommodation/conference expenses from Servier and GSK. SK ist employed at MSD. DZ has received travel/accommodation/conference expenses from AMGEN. LW has received honoraria from Roche and Taiho. CBW has received honoraria from Bayer, Celgene, Janssen, Ipsen, F. Hoffmann-La Roche Ltd, Servier and Taiho, served in a consulting/advisory role for BMS, Celgene, Janssen, Merck, Shire/Baxalta, Rafael Pharmaceuticals, RedHill BioPharma and F. Hoffmann-La Roche Ltd, has received travel/accommodation expenses from Bayer, Celgene, Janssen, RedHill BioPharma, F. Hoffmann-La Roche Ltd, Servier, Taiho, and has received research funding from F. Hoffmann-La Roche Ltd. MvB reports receiving honoraria, research funding and reports being part of the speakers bureau from/of MSD Sharp & Dohme, Novartis, Roche, KITE/Gilead, Bristol-Myers Squibb, Astellas, Mologen and Miltenyi. VH has received honoraria from Merck, Roche, Celgene, AMGEN, Sanofi, Lilly, SIRTEX, Boehringer-Ingelheim, Taiho and Servier, served in a consulting/advisory role for Merck, Roche, AMGEN, Sanofi, SIRTEX, Servier, Celgene, Boehringer-Ingelheim, Halozyme, MSD and BMS, has received research funding from MERCK, Roche, AMGEN, SIRTEX, Servier, Celgene, Boehringer-Ingelheim and Shire, and has received travel/accommodation expenses from MERCK, Roche, AMGEN, SIRTEX, Servier, Shire, MSD, BMS. SB served in a consulting/advisory role for Celgene, Baxalta, Incyte, Fresenius, AstraZeneca, has received honoraria from Celgene and Servier, and has received research funding (institution) from Celgene, Clovis Oncology and Roche. SH served in a consulting/advisory role for VolitionSPRL and Roche, has received honoraria from VolitionSPRL, Roche, Merck, HISS, Streck, BMS, and has received research funding (institution) from VolitionSPRL, Roche, Promega and Mikrogen. The other authors have not declared any competing interests.
: This study was performed in line with the principles of the Declaration of Helsinki. The study has been approved by the local ethics committee of the Ludwig-Maximilians-University Munich (approval number 284–10); all patients had given written informed consent before any study-specific procedure was performed.